Table 2 Accuracy of patient-reported receipt of specific medication
From: Accuracy of self-reported cancer treatment data in young breast cancer survivors
Chemotherapy | N | % Correct |
|---|---|---|
Doxorubicin/cyclophosphamide | 5 | 60 |
AC-T, TAC, or AC-D | 57 | 95 |
TC | 30 | 77 |
CMF | 1 | 100 |
Carboplatin | 12 | 92 |
Paclitaxel | 14 | 29 |
Capecitabine | 3 | 67 |
Abraxane | 3 | 0 |
Targeted Therapy | ||
Trastuzumab | 33 | 100 |
Pertuzumab | 9 | 100 |
Bevacizumab | 1 | 100 |
Niratinib | 1 | 0 |
Palbociclib | 1 | 0 |
Hormonal Therapy | ||
Tamoxifen | 83 | 95 |
Letrozole | 21 | 76 |
Anastrozole | 24 | 62 |
Exemestane | 10 | 60 |
Leuprolide | 8 | 88 |
Goserelin | 7 | 71 |